Earnings ·
Phibro Animal Health reports record full-year net sales of $1,518.1 million, a 17% increase
PAHCPhibro Animal Health Corp
Phibro Animal Health Corporation reported fourth quarter and fiscal year 2026 results, announcing record full-year net sales of $1,518.1 million, a 17% increase, driven by the MFA acquisition and strong demand in Animal Health and Mineral Nutrition segments. Full-year diluted EPS rose 48% to $3.22 on adjusted basis, while Adjusted EBITDA increased 39% to $255.0 million. The company provided fiscal year 2027 guidance projecting net sales of $1.55 billion to $1.60 billion and Adjusted EBITDA of $258 million to $268 million. Additionally, Phibro announced the planned closure of its Chicago Heights manufacturing facility by summer 2027 as part of a strategic network consolidation following the MFA acquisition, affecting approximately 100 employees. The company operates in the animal health and mineral nutrition industry.